Oramed Pharmaceuticals Inc.
TypePublic company
Nasdaq: ORMP
Russell Microcap Index component
IndustryBiotech
Founded2006 (2006)
Headquarters
Jerusalem
Key people
Nadav Kidron (CEO)
Websiteoramed.com

Oramed Pharmaceuticals, or Oramed (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

History

Oramed Pharmaceuticals was founded in 2006 by Miriam Kidron, a scientist at the Hadassah University Hospital in Jerusalem, and her son Nadav Kidron.[1][2]

Product pipeline

Oramed considers its flagship product to be an oral insulin capsule developed to treat sufferers of type 2 diabetes. The Company is currently conducting Phase 3 trials, under the FDA, for oral insulin in Type 2 diabetes.

In addition to the oral insulin capsule, Oramed is developing an exenatide-based capsule designed to balance blood sugar levels and control appetite, and is conducting clinical trials for the treatment of NASH with oral insulin.[3]

In 2021, Oramed created a subsidiary, Oravax Medical, to bring an oral Covid-19 vaccine to market.[4]

In January 2023, Phase 3 trial of Oramed's orally administered insulin for Type 2 diabetes patients failed thus causing the share price to plunge.[5]

In May 2023, Ben Shapiro invested $4.7 million and was named to the board of directors.[6]

See also

References

  1. ↑ Weinreb, Gali (15 January 2013). "Insulin pill co Oramed jumps on Nasdaq listing plans". Globes. Retrieved 16 February 2013.
  2. ↑ Blackburn, Nicky (24 June 2007). "Israeli patent moves closer to achieving oral insulin treatment". Israel21c. Retrieved 16 February 2013.
  3. ↑ "Oramed Initiates Phase 2 NASH Trial of Oral Insulin". www.prnewswire.com. Retrieved 26 August 2021.
  4. ↑ "Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines". www.prnewswire.com. Retrieved 26 August 2021.
  5. ↑ "Oramed plunges after reporting trial failure". Globes. Retrieved 4 May 2023.
  6. ↑ "Conservative Pundit Ben Shapiro Invests $4.7 Million in Israeli Drug Company". Bloomberg. Retrieved 4 May 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.